Article info
PDFLetters
Treatment with etanercept of autoimmune hepatitis associated with rheumatoid arthritis: an open label proof of concept study
- Correspondence to Professor Pierre Miossec, Departments of Clinical Immunology and Rheumatology, Hôpital Edouard Herriot, 69437 Lyon Cedex 03, France; miossec{at}univ-lyon1.fr
Citation
Treatment with etanercept of autoimmune hepatitis associated with rheumatoid arthritis: an open label proof of concept study
Publication history
- Received September 26, 2011
- Accepted January 31, 2012
- First published March 8, 2012.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions